Profusa, Inc.

Profusa, Inc. (Nasdaq: PFSA) is a digital health and medical technology company focused on continuous tissue-based biosensing, operating as a post-merger public entity following a SPAC business combination. The company develops implantable hydrogel biosensors engineered to monitor key biomarkers in real time from within body tissue, with applications targeting health monitoring, chronic disease management, and human performance optimization. Profusa filed a Form 10-Q with the Securities and Exchange Commission on December 17, 2024, covering its most recent quarterly financial period and reflecting its ongoing obligations as a reporting company in the digital health sector. Sign up on SpacDesk for full filing history, sponsor data, and SPAC transaction analytics on PFSA.